The partnership will combine technological innovation and operational expertise to build a more efficient and patient-centered chronic disease service model, supporting the industry's shift from a narrow focus supplying medication towards more comprehensive patient support. As part of the collaboration, Tenry Pharmaceutical's innovative GLP-1 therapy, Paidakang® (派达康, injectable vipeglutide), is expected to make its nationwide debut through Fangzhou's Internet hospital platform. With years of experience in ...

WUHAN, China, May 13, 2026 (GLOBE NEWSWIRE) -- Fangzhou Inc. (“Fangzhou” or the “Company”) (HKEX: 06086), a leading provider of AI‑driven Internet healthcare solutions, participated in the 2026 National Medical Industry Academic and Industry Integration Conference, held from May 6 to 9 in Wuhan. At the health management sub‑forum, Fangzhou presented its innovative “AI+Chronic Disease Service” solutions, addressing some of the most pressing challenges in chronic disease care. AI+H2H Ecosystem Underpins Full‑ ...